EcoR1 Capital LLC 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:30 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 132,579 0.100% |
-7,066,121 (-98.16%) |
Filing |
| 2023-06-16 4:12 pm Purchase |
2023-06-07 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 7,198,700 6.800% |
2,720,650 (+60.76%) |
Filing |
| 2023-01-23 12:14 pm Purchase |
2023-01-10 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 4,478,050 5.000% |
199,981 (+4.67%) |
Filing |
| 2022-06-27 4:33 pm Purchase |
2022-06-16 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 4,278,069 5.800% |
4,278,069 (New Position) |
Filing |